Transcriptomic alterations including p53 pathway dysregulation prime DNMT3A mutant cells for transformation
Erin Lawrence, Amali Cooray, Andrew J. Kueh, Martin Pál, Lin Tai, Alexandra L. Garnham, Connie S.N. Li Wai Suen, Hannah Kate Vanyai, Quentin A. Gouil, James Lancaster, Sylvie Callegari, Lauren Whelan, Elizabeth Lieschke, Annabella Thomas, Andreas Strasser, , Marco J. Herold
This study shows DNMT3A mutations reduce DNA methylation and disrupt p53 pathway, increasing self-renewal and cancer risk in hematopoietic cells.
EMBO Reports · Apr 30, 2025Peer-reviewedCancer Biology